Autopsy report · NCT03999580
The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )
Cause of deathStaffing, sites or logistics, also funding or business
“Enrollment stopped at 55 of 316 planned participants due to recruitment challenges related to the COVID-19 pandemic and funding constraints. All enrolled participants completed 52-week follow-up.”
Life of this trial
- Registered 7 months before it started.
- Ran for about 3 years 8 months before it stopped.
- 55 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Jantchou Prevost
- Sponsor type
- University, hospital or other
- Conditions
- Crohn Disease
- Interventions
- vitamin D3
- Participants
- 55
- Sites
- 7
- Countries
- Canada
Trials that died the same way
- An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
“Recruitment/enrollment ended early due to the COVID-19 pandemic” - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
“Enrollment halted prematurely due to the Covid-19 pandemic” - Evaluating a Novel Web-based Intervention for Breast Cancer Survivors
“Participant recruitment was stopped due to corona pandemic.” - Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
“Recruitment was stopped before the planned sample size was reached owing to the Covid-19 pandemic and expiration of funding.” - Ultrasound and Endometrial Hyperplasia
“enrollment of participants has halted prematurely; difficulty with recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.